Norman E. Lepor
- Surgery top 2%
- Economics and Econometrics top 2%
- Endocrinology, Diabetes and Metabolism top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Immunology top 10%
- Co-authors
- Michel FarnierErik S.G. StroesFrederick J. RaalRobert PordyJohn J.P. KasteleinChristelle LorenzatoJean BergeronMichael J. Koren
- Topics
- Lipoproteins and Cardiovascular Health (7 papers)Cancer, Lipids, and Metabolism (3 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers)
- Partner nations
- United StatesCanadaPoland
In The Last Decade
Norman E. Lepor
13 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Surgery 1.8k
- Economics and Econometrics 656
- Endocrinology, Diabetes and Metabolism 473
- Cardiology and Cardiovascular Medicine 460
- Immunology 291
Countries citing papers authored by Norman E. Lepor
This map shows the geographic impact of Norman E. Lepor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman E. Lepor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman E. Lepor more than expected).
Fields of papers citing papers by Norman E. Lepor
This network shows the impact of papers produced by Norman E. Lepor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman E. Lepor. The network helps show where Norman E. Lepor may publish in the future.
Co-authorship network of co-authors of Norman E. Lepor
This figure shows the co-authorship network connecting the top 25 collaborators of Norman E. Lepor. A scholar is included among the top collaborators of Norman E. Lepor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman E. Lepor. Norman E. Lepor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 72 | |
| 5 | Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled studybreakdown → | 294 |
| 6 | 1 | |
| 7 | 15 | |
| 8 | 5 | |
| 9 | Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Eventsbreakdown → | 1683 |
| 10 | The rosiglitazone meta-analysis. | 5 |
| 11 | 4 | |
| 12 | 266 | |
| 13 | 15 |
About Norman E. Lepor
Norman E. Lepor is a scholar working on Biochemistry, Nephrology and Cancer Research, having authored 13 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (7 papers), Cancer, Lipids, and Metabolism (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Surgery (1.8k citations), Nephrology (268 citations) and Endocrinology, Diabetes and Metabolism (473 citations). Norman E. Lepor has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Michel Farnier, Erik S.G. Stroes, Frederick J. Raal, Robert Pordy, John J.P. Kastelein, Christelle Lorenzato, Jean Bergeron, Michael J. Koren, Mahfouz El Shahawy and Gérald Luc. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.